Platycodin D Enhances Glioma Sensitivity to Temozolomide by Inhibition of the Wnt/β-Catenin Pathway
Drug Design, Development and Therapy · 2025
DOI: 10.2147/dddt.s503167 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Haima Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The Nuclear Industry 215 hospital of Shaanxi Province, Xianyang, Shaanxi, 712000, People's Republic of China. Hauptthemen laut MEDLINE: Temozolomide, Glioma, Wnt Signaling Pathway, Saponins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, The Nuclear Industry 215 hospital of Shaanxi Province, Xianyang, Shaanxi, 712000, People's Republic of China.
- Department of Neurosurgery, Peking University People's Hospital, Beijing, 100044, People's Republic of China.
- Department of Neurosurgery, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi, 710038, People's Republic of China.
Zitieren
APA
Li, H., Ouyang, J., Wang, X., & Qian, C. (2025). Platycodin D Enhances Glioma Sensitivity to Temozolomide by Inhibition of the Wnt/β-Catenin Pathway. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s503167
Vancouver
Li H, Ouyang J, Wang X, Qian C. Platycodin D Enhances Glioma Sensitivity to Temozolomide by Inhibition of the Wnt/β-Catenin Pathway. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s503167
BibTeX
@article{Li2025,
author = {Li, Haima and Ouyang, Jia and Wang, Xuelian and Qian, Chao},
title = {Platycodin D Enhances Glioma Sensitivity to Temozolomide by Inhibition of the Wnt/β-Catenin Pathway},
journal = {Drug Design, Development and Therapy},
year = {2025},
doi = {10.2147/dddt.s503167}
}
EUVIMED